当前位置： SCI文献检索 > JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY期刊下所有文献 > Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales.

Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales.

Abstract：

:Drug-associated extrapyramidal symptoms (EPS) in people with intellectual disability (ID) may be difficult to recognize, and clinicians' assessments may be hampered by lack of patients' capacities to adequately cooperate and by lack of reliable instruments to measure EPS in this population. Therefore, we compared assessments based on professional caregivers' observations with the informant-based validated Matson Evaluation of Drug Side Effects (MEDS) scale with assessments by clinicians using a set of clinical rating scales, most of which have not been validated for use in this population. We also compared 2 dyskinesia scales by replacing the widely used but not validated Abnormal Involuntary Movement Scale with the validated Dyskinesia Identification System Condensed User Scale (DISCUS) in half of the set of scales. We used linear regression to analyze associations between EPS as measured with MEDS and EPS as measured with the sets of scales at item and at scale level.Of the 30 MEDS items, 6 were associated with items of the other scales. At scale level, we found no significant associations. Comparison of the Abnormal Involuntary Movement Scale with the DISCUS indicated that the DISCUS may be preferable for use in people with ID.Results may be explained by shortcomings in education and training of caregivers and by lack of reliable assessments and rating scales for EPS in people with ID.We conclude that there is an urgent need for education and training of care professionals and clinicians in this area and for studies investigating the psychometric properties of rating scales.

journal_name

J Clin Psychopharmacol

journal_title

Journal of clinical psychopharmacology

authors

de Kuijper GM,Hoekstra PJ

doi

10.1097/JCP.0000000000000558

subject

Has Abstract

pub_date

2016-10-01 00:00:00

pages

508-12

issue

5

eissn

0271-0749

issn

1533-712X

journal_volume

36

pub_type

杂志文章

相关文献

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY文献大全
  • Meta-regression analysis of paroxetine clinical trial data: does reporting scale matter?

    abstract：OBJECTIVES:It is unknown to which degree the effect of antidepressant drugs are related to baseline degree of depression, dose level, patient's age, or type of questionnaire used. We explored this for paroxetine. METHODS:We used placebo-controlled published and unpublished randomized, double-blind, clinical trials of ...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,meta分析

    doi：10.1097/JCP.0b013e318210bac1

    authors： Klemp M,Tvete IF,Gåsemyr J,Natvig B,Aursnes I

    更新日期：2011-04-01 00:00:00

  • Comparative abuse liability of intravenously administered remifentanil and fentanyl.

    abstract：:Remifentanil is a short-acting, esterase-metabolized opioid analgesic. This study compared the abuse liability of remifentanil with that of fentanyl and placebo in a randomized, double-blind, crossover study. Twelve recreational users of opioids received increasing doses of remifentanil (0.6, 1.2, 1.8, 2.4, and 3.0 mi...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1097/00004714-200012000-00002

    authors： Baylon GJ,Kaplan HL,Somer G,Busto UE,Sellers EM

    更新日期：2000-12-01 00:00:00

  • Amoxapine versus amitriptyline for continuation therapy of depression.

    abstract：:The efficacy of continuation therapy with tricyclic antidepressants has been established in a number of controlled trials. This study investigated the efficacy of continuation therapy with a relatively new antidepressant, amoxapine, using a double-blind controlled comparison with amitriptyline. Subjects met DSM-III cr...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Mason BJ,Kocsis JH,Frances AJ,Mann JJ

    更新日期：1990-10-01 00:00:00

  • Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.

    abstract：:A double-blind controlled study comparing the effects of bupropion to doxepin in outpatients with primary depression was conducted to evaluate efficacy and safety differences between the two drugs. Following a 7-day placebo washout period, patients could be treated for up to 13 weeks on either treatment. Antidepressan...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Feighner J,Hendrickson G,Miller L,Stern W

    更新日期：1986-02-01 00:00:00

  • Predictors for starting depot administration of risperidone in chronic users of antipsychotics.

    abstract：BACKGROUND:Risperidone long-acting injectable (RLAI), the first second-generation depot antipsychotic, has extensively been studied before introduction. Thereafter, questions about the type of patients actually treated with RLAI in daily practice remain to be answered for making valid antipsychotic treatment comparison...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章

    doi：10.1097/JCP.0b013e31818a6d10

    authors： Vehof J,Postma MJ,Bruggeman R,De Jong-Van Den Berg LT,Van Den Berg PB,Stolk RP,Burger H

    更新日期：2008-12-01 00:00:00

  • Optimizing early prediction for antipsychotic response in schizophrenia.

    abstract：OBJECTIVE:Researchers, by studying first-generation antipsychotics, have established an early prediction model, which had a favorable specificity but a low sensitivity. This study aims to optimize early prediction of treatment response for schizophrenia using a novel statistic method that can be done even under the Mic...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1097/01.jcp.0000246211.95905.8c

    authors： Chang YC,Lane HY,Yang KH,Huang CL

    更新日期：2006-12-01 00:00:00

  • Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder.

    abstract：:The aim of this post-hoc analysis was to determine whether early symptom improvement with extended release quetiapine (quetiapine XR) may predict treatment outcome in patients with major depressive disorder. Data were from 6, double-blind, placebo-controlled studies of quetiapine XR (2 fixed-dose and 2 flexible-dose m...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,meta分析

    doi：10.1097/JCP.0000000000000416

    authors： McIntyre RS,Gorwood P,Thase ME,Liss C,Desai D,Chen J,Bauer M

    更新日期：2015-12-01 00:00:00

  • Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.

    abstract：PURPOSE/BACKGROUND:To add to limited evidence on the Abnormal Involuntary Movement Scale (AIMS) as a measure of tardive dyskinesia (TD) in clinical practice settings, the characteristics and correlates of AIMS scores were assessed. METHODS/PROCEDURES:Veterans with schizophrenia/schizoaffective, bipolar, or major depre...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章

    doi：10.1097/JCP.0000000000001229

    authors： Caroff SN,Leong SH,Roberts CB,Berkowitz RM,Campbell EC

    更新日期：2020-07-01 00:00:00

  • Effect of erythromycin on tricyclic antidepressant metabolism.

    abstract：:Macrolide antibiotics such as erythromycin have been found to impair the hepatic metabolism of carbamazepine. In addition, recent studies have shown that intestinal flora can N-demethylate tricyclic antidepressants, suggesting that the human gut may be a possible site of extrahepatic drug metabolism. Therefore, we con...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章

    doi：

    authors： Amsterdam JD,Maislin G

    更新日期：1991-06-01 00:00:00

  • Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline.

    abstract：PURPOSE:This post hoc meta-analysis evaluated the efficacy and safety of desvenlafaxine 50 and 100 mg versus placebo across age groups and severity of depression at baseline in patients with major depressive disorder. METHODS:Data from placebo and desvenlafaxine 50-mg and 100-mg dose arms were pooled from 9 short-term...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,meta分析

    doi：10.1097/JCP.0000000000000674

    authors： Mosca D,Zhang M,Prieto R,Boucher M

    更新日期：2017-04-01 00:00:00

  • Trends in the adoption of medications for alcohol dependence.

    abstract：:Increasing attention is being paid to the development and dissemination of effective pharmacotherapies for the treatment of alcohol and other drug dependence. However, numerous structural and philosophical barriers impede the widespread adoption of these treatment approaches in everyday clinical practice. Research is ...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,meta分析,评审

    doi：10.1097/01.jcp.0000246209.18777.14

    authors： Ducharme LJ,Knudsen HK,Roman PM

    更新日期：2006-12-01 00:00:00

  • Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder.

    abstract：:The objective of this study was to compare the efficacy of the alpha-2a agonist guanfacine with that of dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder (ADHD). Seventeen adult outpatients who met DSM-IV criteria for ADHD participated in a double-blind, placebo-controlled, crossove...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1097/00004714-200104000-00015

    authors： Taylor FB,Russo J

    更新日期：2001-04-01 00:00:00

  • Pharmacokinetics of valproate and carbamazepine.

    abstract：:Over the past 10 years, knowledge gained about the pharmacokinetic profiles of valproate and carbamazepine has increased the clinical effectiveness of their use. Much of the information has been gained through their use as successful antiepileptic medications. As these agents begin to play an increasing role as mood-s...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章

    doi：10.1097/00004714-199202001-00010

    authors： Wilder BJ

    更新日期：1992-02-01 00:00:00

  • Risperidone: an open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia.

    abstract：OBJECTIVE:Efficacy of atypical antipsychotic in acute schizophrenic episodes is still in debate. This study evaluated treatment practices over 7 years of initial treatment with oral risperidone in acutely exacerbated patients with schizophrenia and in a subgroup of highly agitated, tense, and aggressive patients. Addit...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1097/01.jcp.0000170686.27476.ab

    authors： Pajonk FG,Schreiner A,Peters S,Rettig K,Degner D,Rüther E

    更新日期：2005-08-01 00:00:00

  • Inhibition of CYP2D6 activity by bupropion.

    abstract：:The purpose of this study was to assess the effect of bupropion on cytochrome P450 2D6 (CYP2D6) activity. Twenty-one subjects completed this repeated-measures study in which dextromethorphan (30-mg oral dose) was administered to smokers at baseline and after 17 days of treatment with either bupropion sustained-release...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1097/01.jcp.0000162805.46453.e3

    authors： Kotlyar M,Brauer LH,Tracy TS,Hatsukami DK,Harris J,Bronars CA,Adson DE

    更新日期：2005-06-01 00:00:00

  • Imipramine disposition in alcoholics.

    abstract：:The disposition of orally administered imipramine (IMI) was studied in 11 depressed alcoholic and 12 depressed nonalcoholic male inpatients. Subjects received 50 mg three times daily for at least 10 days to ensure steady state. Following a temporary discontinuation of therapy, several blood samples were drawn over a 4...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章

    doi：10.1097/00004714-198202000-00002

    authors： Ciraulo DA,Alderson LM,Chapron DJ,Jaffe JH,Subbarao B,Kramer PA

    更新日期：1982-02-01 00:00:00

  • Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin.

    abstract：:The therapeutic spectrum of nemonapride, a new substituted benzamide, and its relationship with plasma concentrations of the drug and prolactin were investigated by a fixed-dose study (18 mg/day for 3 weeks) in 31 patients with acutely exacerbated schizophrenia. Of 31 patients, 25 (80.6%) were responders who showed a ...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1097/00004714-200008000-00003

    authors： Kondo T,Mihara K,Yasui N,Nagashima U,Ono S,Kaneko S,Ohkubo T,Osanai T,Sugawara K,Otani K

    更新日期：2000-08-01 00:00:00

  • Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine.

    abstract：:Hypersalivation is a frequent, disturbing, and uncomfortable adverse effect of clozapine therapy that frequently leads to noncompliance. The aim of this study was to examine the efficacy of metoclopramide (dopamine D2 antagonist, antiemetic medication) as an option for management of hypersalivation associated with clo...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1097/JCP.0000000000000493

    authors： Kreinin A,Miodownik C,Mirkin V,Gaiduk Y,Yankovsky Y,Bersudsky Y,Lerner PP,Bergman J,Lerner V

    更新日期：2016-06-01 00:00:00

  • Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?

    abstract：:In a double-blind, parallel groups study, 60 healthy student volunteers (29 men and 31 women, aged 19-22 years) were randomly allocated to receive placebo, 100 or 200 mg modafinil. Two hours later, in the early evening, they completed an extensive cognitive battery. The 3 groups did not differ in self-ratings of sleep...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1097/01.jcp.0000155816.21467.25

    authors： Randall DC,Viswanath A,Bharania P,Elsabagh SM,Hartley DE,Shneerson JM,File SE

    更新日期：2005-04-01 00:00:00

  • An open clinical trial of fluoxetine in the treatment of premature ejaculation.

    abstract：:There have been an increased number of recent reports on orgasm-related sexual dysfunction coincident with selective serotonin reuptake inhibitor (SSRI) treatment. In contrast, it has also been reported that SSRIs improve sexual dysfunction. Low doses of clomipramine and paroxetine, potent 5-hydroxytryptamine reuptake...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1097/00004714-199610000-00006

    authors： Lee HS,Song DH,Kim CH,Choi HK

    更新日期：1996-10-01 00:00:00

  • Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.

    abstract：:The selective serotonin reuptake inhibitor antidepressant fluoxetine inhibits alprazolam metabolism in vivo by inhibition of the cytochrome P450 3A4 enzyme. Citalopram is a selective serotonin reuptake inhibitor antidepressant that has not yet been fully evaluated with respect to its potential for cytochrome P450 3A4-...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1097/01.jcp.0000085407.08426.e1

    authors： Hall J,Naranjo CA,Sproule BA,Herrmann N

    更新日期：2003-08-01 00:00:00

  • Fluoxetine: activating and sedating effects at multiple fixed doses.

    abstract：:Serotonin uptake inhibitors are generally considered activating antidepressants. To assess rates and temporal patterns of activation and sedation as well as dose-effect relationships, adverse event data were evaluated from a fixed-dose study comparing placebo and fluoxetine 5, 20, and 40 mg/day in the treatment of maj...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：

    authors： Beasley CM Jr,Sayler ME,Weiss AM,Potvin JH

    更新日期：1992-10-01 00:00:00

  • Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations.

    abstract：BACKGROUND:Pharmacokinetic-pharmacodynamic (PK/PD) models were developed to describe the relationship between the time course of paliperidone plasma concentrations and the risk of relapse of schizophrenia symptoms following administration of paliperidone palmitate 1-month (PP1M) and 3-month (PP3M) long-acting injectabl...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1097/JCP.0000000000001137

    authors： Russu A,Savitz A,Mathews M,Gopal S,Feng Y,Samtani MN

    更新日期：2019-11-01 00:00:00

  • Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?

    abstract：:Seventeen hospitalized psychotic patients were treated with a fixed oral dose of haloperidol, 5 mg twice daily for 28 days. Most were chronic schizophrenics with an acute exacerbation of their illness. All patients also received benztropine 3 mg twice daily during the last 11 days of the study, regardless of the prese...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章

    doi：

    authors： Shostak M,Perel JM,Stiller RL,Wyman W,Curran S

    更新日期：1987-12-01 00:00:00

  • Effect of Rivastigmine Augmentation in Treatment of Male Patients With Combat-Related Chronic Posttraumatic Stress Disorder: A Randomized Controlled Trial.

    abstract：BACKGROUND:Posttraumatic stress disorder (PTSD) is one of the chronic and disabling psychiatric disorders, particularly in combat veterans. In a case series, rivastigmine was suggested to be an effective augmentation in treatment of PTSD. The aim of the present study was to evaluate this finding in a randomized control...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1097/JCP.0000000000000624

    authors： Rezaei Ardani A,Hosseini G,Fayyazi Bordbar MR,Talaei A,Mostafavi Toroghi H

    更新日期：2017-02-01 00:00:00

  • Placebo-controlled trial of zonisamide for the treatment of alcohol dependence.

    abstract：INTRODUCTION:Zonisamide is an anticonvulsant medication with GABAergic, glutamatergic, and monoaminergic effects. Zonisamide has also been shown to reduce alcohol intake in rodents and in risky drinkers in the context of a laboratory study. This pilot clinical trial evaluated the safety, tolerability, and efficacy of z...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1097/JCP.0b013e3181db38bb

    authors： Arias AJ,Feinn R,Oncken C,Covault J,Kranzler HR

    更新日期：2010-06-01 00:00:00

  • Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia.

    abstract：OBJECTIVE:This prospective study sought to compare the acute effects of haloperidol, amisulpride, and quetiapine on serum markers of bone formation and resorption in relatively young patients with minimal previous exposure to antipsychotic drugs. METHODS:Patients included in the study were randomly assigned to receive...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1097/JCP.0000000000000379

    authors： Liang Y,Su YA,Zhao ZG,Gao N,Huang JZ,Tang MQ,Li KQ,Yang FD,Yu X,Si TM

    更新日期：2015-10-01 00:00:00

  • Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder.

    abstract：:A role for serotonin in season affective disorder (SAD) has been explored with a variety of serotonergic pharmacologic agents. The authors initially hypothesized that metergoline, a nonspecific serotonin antagonist, would exacerbate depressive symptoms. In a small, open-label pilot study, the authors observed the oppo...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1097/00004714-200204000-00018

    authors： Turner EH,Schwartz PJ,Lowe CH,Nawab SS,Feldman-Naim S,Drake CL,Myers FS,Barnett RL,Rosenthal NE

    更新日期：2002-04-01 00:00:00

  • Aripiprazole in schizophrenia with cocaine dependence: a pilot study.

    abstract：:The debilitation of schizophrenia (SCHZ) worsens markedly with comorbid cocaine dependence (CD) and alcohol abuse. To date, no medications have conclusively demonstrated effects against both SCHZ and CD (SCHZ + CD) simultaneously. Because of its dopamine-modulating properties, we hypothesized that aripiprazole would a...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1097/01.jcp.0000169419.38899.5b

    authors： Beresford TP,Clapp L,Martin B,Wiberg JL,Alfers J,Beresford HF

    更新日期：2005-08-01 00:00:00

  • Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.

    abstract：:Adverse events during selective serotonin reuptake inhibitor (SSRI) treatment are frequent and may lead to premature treatment discontinuation. If attrition is associated with early worsening of adverse effects or the frequency, intensity, or burden of adverse effects, interventions to maximize retention could be focu...

    journal_title：Journal of clinical psychopharmacology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1097/JCP.0b013e3181dbfd04

    authors： Warden D,Trivedi MH,Wisniewski SR,Kurian B,Zisook S,Kornstein SG,Friedman ES,Miyahara S,Leuchter AF,Fava M,Rush AJ

    更新日期：2010-06-01 00:00:00